Dual mode of cell death upon the photo-irradiation of a Ru II polypyridyl complex in interphase or mitosis
Open Access
- 1 June 2016
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 7 (9) , 6115-6124
Abstract
Photodynamic therapy (PDT) is an attractive, complementary medical technique to chemotherapy. Among the different photosensitizers (PSs) employed, Ru(II) polypyridyl complexes were found to be valid substitutes to porphyrin-based or phthalocyanine-based PSs. Here, we confirm that one such complex, namely [Ru(bipy)2-dppz-7-methoxy][PF6]2 (Ru65), which localizes in the nucleus of various cancer and normal cells, displays cytotoxicity only upon UV-A irradiation. Importantly, we disclose the molecular mechanism of the UV-A mediated cytotoxic action of Ru65. We demonstrate that Ru65 intercalates in DNA and, upon light irradiation, promotes guanine oxidation, resulting in nicks in the double helix. We confirm this mechanism of action in living cells, showing that the UV-A irradiation of cells loaded with Ru65 results in a transient DNA damage response and cell death. Strikingly, the photo-irradiation of Ru65 triggered distinct mechanisms of cell death in interphase or mitotic cells. The former underwent cell cycle arrest at the G2/M phase and massive cytoplasmic vacuolation, which was paralleled by an unfolded-protein stress response, resulting in a reduction of viability and cell death through a paraptosis-like mechanism. On the other hand, the UV-A irradiation of Ru65 in cells synchronized by G2/M block-release with a selective CDK1 inhibitor led to blocking mitotic entry and rapid cell death through classic apoptotic pathways. Importantly, targeting mitotic cells with Ru65 allowed increasing its photo-toxicity by a factor of 3.6. Overall, our findings show that the use of a combination of a cell cycle inhibitor and a PS targeting the nucleus could open up new avenues in PDT.Keywords
Funding Information
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (SNF 31003A-127054)
- Universität Zürich
This publication has 47 references indexed in Scilit:
- Targeting tumour-supportive cellular machineries in anticancer drug developmentNature Reviews Drug Discovery, 2014
- The DNA damage response and cancer therapyNature, 2012
- Principles of Cancer Therapy: Oncogene and Non-oncogene AddictionCell, 2009
- Photodynamic Therapy: Other UsesDermatologic Clinics, 2007
- Mechanisms in photodynamic therapy: part one—photosensitizers, photochemistry and cellular localizationPhotodiagnosis and Photodynamic Therapy, 2004
- Photodynamic therapy for cancerNature Reviews Cancer, 2003
- Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemiaCancer Cell, 2002
- Photodynamic therapy in oncologyExpert Opinion on Pharmacotherapy, 2001
- Palliation of esophageal malignancy with photoradiation therapyCancer, 1984
- Hematoporphyrin Derivative and Laser Photoradiation in the Treatment of Lung CancerChest, 1982